Fragment-based drug discovery (FBDD) is an efficient methodology for the generation of lead compounds. However, structure-based optimisation of weakly binding fragments into high affinity drug molecules often means that difficult synthetic challenges arise, hence there is a growing demand for cutting-edge synthetic methods and experimental techniques. This project focusses on machine-learning methodologies to more effectively plan and execute synthetic sequences to obtain desired target molecules mandated by FBDD optimisation.